Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kilian Kelly Insider Profile
4 Followers
Kilian Kelly, Chief Executive Officer & Managing Director at Cynata Therapeutics Limited, holds 797.43K shares in Cynata Therapeutics Limited (Ticker: CYYNF). Most recently, Kilian Kelly Bought $177,777 shares of Cynata Therapeutics Limited on Jan 23, 2025 for an estimated value of 32.00K.
Kilian Kelly Cynata Therapeutics Limited (CYYNF)Chief Executive Officer & Managing Director
Cynata Therapeutics Limited (CYYNF)
Chief Executive Officer & Managing Director
Ranked #25,521 out of 100,443 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+81.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Executive Officer & Managing Director
Roles that Kilian Kelly holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 22, 2023 - Nov 22, 2024
Return:+163.80%
The most profitable trade made by Kilian Kelly
Kilian Kelly's Trading History
List of latest transactions for each holding click on a transaction to see Kilian Kelly's performance on stock
You May Also Like
Kilian Kelly insider profile FAQ
What is the percentage of profitable transactions made by Kilian Kelly?
The percentage of profitable transactions made by Kilian Kelly is 50%.
What is the average return per transaction made by Kilian Kelly?
The average return per transaction made by Kilian Kelly is 81.90%.
What stocks does Kilian Kelly hold?
Kilian Kelly holds: CYYNF stocks.
What was Kilian Kelly’s latest transaction?
Kilian Kelly latest transaction was an Informative Buy of $32.00K.
What was Kilian Kelly's most profitable transaction?
Kilian Kelly’s most profitable transaction was an Informative Buy of CYYNF stock on November 22, 2023. The return on the trade was 163.80%.
What is Kilian Kelly's role in Cynata Therapeutics Limited?
Kilian Kelly's role in Cynata Therapeutics Limited is Chief Executive Officer & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.